DAEWOONG Pharmaceutical Co. Ltd.’s technology, through its latest neurotoxin drug Nabota, is expecting to double its target share of the Philippine aesthetic market by next year on the back of a strong local sales force. Nabota Philippines Brand Manager Christopher Cachuela told the BusinessMirror they are on track to meet their 2015 goal of 15 percent…